Intrinsic Value of S&P & Nasdaq Contact Us

Editas Medicine, Inc. EDIT NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
47/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$6.00
+77%

Stock Statistics — EDIT

Editas Medicine, Inc. (EDIT) has a market capitalization of $331.79M and trades at $3.39. The 52-week range is 0.91-4.537.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.9, Earnings Per Share (EPS) of $-1.80, annual revenue of $40.52M.

The stock has a beta of 2.04, operates in the Healthcare sector.

Trading Data
Current Price$3.39
52-Week Range0.91-4.537
Volume2.31M
Avg Volume (30D)1.73M
Market Cap$331.79M
Beta (1Y)2.04
Company
IPO Date2016-02-03
Employees246
CEOGilmore O'Neill
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS28106W1036
CUSIP28106W103
Income (Latest Year)
Revenue$40.52M
Gross Profit$40.52M
EBITDA$-148.61M
Operating Income$-99.34M
Net Income$-160.06M
EPS$-1.80
EPS Diluted$-1.80
Shares Outstanding$88.75M
Balance Sheet (Latest Year)
Total Assets$186.53M
Current Assets$163.9M
Cash & ST Investments$146.65M
Total Liabilities$159.25M
Total Debt$76.71M
Net Debt$-69.94M
Total Equity$27.29M
Debt / Equity2.81
Valuation Ratios
P/E Ratio-1.9
P/S Ratio8.19
P/B Ratio12.16
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message